Internal Medicine, Pulmonary Disease · Mayaguez, PR
NPI
1528262730
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Cpr Professional Building, 55 Calle de Diego Este Suite 401
Mayaguez, PR, 00680
Phone (787) 832-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,284
100 services
Medicare patients, 2024
27
Average age 76
Drug cost, 2024
$1.6M
6,542 prescriptions
Company payments, 2025
$339
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francisco M Montalvo was code 99213 (office e&m - established), 21 times for 15 patients. In total Francisco M Montalvo billed 100 services in 16 codes, and Medicare paid $5,284.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 21 | 15 | $67.10 | $1,409 |
| 94375 Pulmonary Function Testing | Office | 16 | 13 | $28.35 | $454 |
By year: 2022 $5,232 for 98 services; 2023 $5,428 for 100 services; 2024 $5,284 for 100 services.
Medicare prescription drug claims, 2024
In 2024, the drug Francisco M Montalvo prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,190 prescriptions and refills. In total Francisco M Montalvo wrote 6,542 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,190 | 1,206 | 259 | $54K |
| Montelukast Sodium Generic | 990 | 1,131 | 194 | $8,154 |
| Fluticasone Propionate Generic | 735 | 762 | 172 | $10K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 378 | 392 | 76 | $104K |
| Breo Ellipta Fluticasone/Vilanterol | 316 | 320 | 59 | $130K |
| Dexamethasone Generic | 250 | 250 | 162 | $4,107 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 215 | 219 | 46 | $40K |
| Spiriva Respimat Tiotropium Bromide | 207 | 208 | 45 | $111K |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 207 | 209 | 46 | $13K |
| Fluticasone Propionate Hfa Fluticasone Propionate | 204 | 220 | 46 | $54K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 153 | 153 | 23 | $102K |
| Levocetirizine Dihydrochloride Generic | 106 | 106 | 24 | $1,207 |
| Prednisone Generic | 94 | 94 | 16 | $481 |
| Famotidine Generic | 86 | 86 | 29 | $545 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 81 | 81 | 22 | $53K |
Brand drugs: 2,946 claims; generic drugs: 3,584 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Francisco M Montalvo $339 ($339 in general payments such as food, travel and fees) from 4 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $167.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.